Three-dimensional growth reveals fine-tuning of 5-lipoxygenase by proliferative pathways in cancer
Life Science Alliance · 2023-05 · 6 (5) · e202201804
DOI: 10.26508/lsa.202201804 ↗At a glance
Journal article in Life Science Alliance, published online on 2023-02-27. Written by Tamara Göbel and 8 co-authors. Institution: Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany. Major MEDLINE topics: Arachidonate 5-Lipoxygenase, Colonic Neoplasms. Cited 3 times so far (Crossref); 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft.
Abstract (original language)
The leukotriene (LT) pathway is positively correlated with the progression of solid malignancies, but the factors that control the expression of 5-lipoxygenase (5-LO), the central enzyme in LT biosynthesis, in tumors are poorly understood. Here, we report that 5-LO along with other members of the LT pathway is up-regulated in multicellular colon tumor spheroids. This up-regulation was inversely correlated with cell proliferation and activation of PI3K/mTORC-2– and MEK-1/ERK-dependent pathways. Furthermore, we found that E2F1 and its target gene MYBL2 were involved in the repression of 5-LO during cell proliferation. Importantly, we found that this PI3K/mTORC-2– and MEK-1/ERK-dependent suppression of 5-LO is also existent in tumor cells from other origins, suggesting that this mechanism is widely applicable to other tumor entities. Our data show that tumor cells fine-tune 5-LO and LT biosynthesis in response to environmental changes repressing the enzyme during proliferation while making use of the enzyme under cell stress conditions, implying that tumor-derived 5-LO plays a role in the manipulation of the tumor stroma to quickly restore cell proliferation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany.
- Institute of Clinical Pharmacology, Pharmazentrum Frankfurt, ZAFES, Goethe University, Frankfurt, Germany.
- Fraunhofer Institute of Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.
- Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany kahnt@pharmchem.uni-frankfurt.de.
ORCID profiles: Astrid S Kahnt
Funding
- Deutsche Forschungsgemeinschaft
Cite
APA
Göbel, T., Goebel, B., Hyprath, M., Lamminger, I., Weisser, H., Angioni, C., Mathes, M., Thomas, D., & Kahnt, A. S. (2023). Three-dimensional growth reveals fine-tuning of 5-lipoxygenase by proliferative pathways in cancer. Life Science Alliance, 6(5), e202201804. https://doi.org/10.26508/lsa.202201804
Vancouver
Göbel T, Goebel B, Hyprath M, Lamminger I, Weisser H, Angioni C, et al. Three-dimensional growth reveals fine-tuning of 5-lipoxygenase by proliferative pathways in cancer. Life Science Alliance. 2023;6(5):e202201804. doi:10.26508/lsa.202201804
BibTeX
@article{Gbel2023,
author = {Göbel, Tamara and Goebel, Bjarne and Hyprath, Marius and Lamminger, Ira and Weisser, Hannah and Angioni, Carlo and Mathes, Marius and Thomas, Dominique and Kahnt, Astrid S},
title = {Three-dimensional growth reveals fine-tuning of 5-lipoxygenase by proliferative pathways in cancer},
journal = {Life Science Alliance},
year = {2023},
volume = {6},
number = {5},
pages = {e202201804},
doi = {10.26508/lsa.202201804}
}
EUVIMED